Aziyo Biologics launches bone matrix for orthopedic surgery

Alan Condon -   Print  |

Regenerative medicine company Aziyo Biologics on June 29 launched OsteoGro V, a viable cell bone matrix to assist with bone repair.

Three things to know:

1. OsteoGro V features cancellous bone particles and demineralized cortical bone particles and fibers to improve product handling.

2. Aziyo Biologics has entered into several private-label distribution agreements, which is expected to boost adoption in the spine, orthopedic and dental markets. 

3. Founded in 2015, Aziyo Biologics' products focus on improving outcomes in implantable device- related complications.

More articles on biologics:
7 celebrity spine surgeries and who performed them — Drs. Robert Watkins, Richard Guyer & more
The future of private practice and payers in spine: 3 key thoughts
Texas hospital suspends construction of $120M spine tower due to economic challenges

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers